Skip to content
April marked the 10-year anniversary of the JOBS (Jumpstart Our Business Startups) Act. The bill, which was signed into law thanks to bipartisan support […]
Looking back on the JOBS Act, 10 years later Read More »
The House Energy & Commerce Health Subcommittee on Wednesday marked up six key bills that address the FDA user fee agreements and some other
FDA user fee agreements advance in House with bipartisan support Read More »
President Biden announced May 4 that the White House will hold a Conference on Hunger, Nutrition, and Health in September, for the first time
White House will host the first food insecurity conference in 50 years Read More »
Pharmacy benefit managers (PBMs) are “part of a broken drug supply chain,” Sen. Richard Blumenthal (D-CT) told a Senate hearing about “Ensuring Fairness and
Senate hearing: PBMs ‘part of a broken drug supply chain’ Read More »
The House Energy & Commerce Committee unveiled on Wednesday “a bipartisan comprehensive legislative package to reauthorize the Food and Drug Administration (FDA) user fee
House unveils package to reauthorize FDA user fee agreements Read More »
The opioid epidemic has hit the United States hard in the last 25 years, killing more than 70,000 in 2019 alone, according to the
FDA draft guidance on non-opioid analgesics ‘inadequate’ Read More »
After unsuccessful attempts to lower Medicare Part D beneficiary cost-sharing, the Centers for Medicare & Medicaid Services (CMS) will finally wrap up a proposal
CMS will apply pharmacy price concessions at point of sale Read More »
A “march-in” petition filed under the Bayh-Dole Act, asking NIH to give competing drug companies the license to produce the prostate cancer drug Xtandi
Panel says attack on the Bayh-Dole Act threatens small businesses Read More »
A broad coalition of 77 companies and associations that are stakeholders in the aviation industry—including the Biotechnology Innovation Organization (BIO) and its member companies,
BIO, business community call for SAF tax incentives Read More »
Today on the House floor, U.S. Rep. Nanette Diaz Barragán (D-CA) spoke out against the recent Centers for Medicare and Medicaid Services (CMS) decision
Rep. Barragán: CMS Alzheimer’s drug decision is ‘a mistake’ Read More »
